Skip to content

Achilles Tendon for the Treatment of Gluteus Medius Insufficiency

Achilles Tendon Homograft for the Treatment of Gluteus Medius Insufficiency After Hip Replacement

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05206838
Acronym
HLS
Enrollment
44
Registered
2022-01-25
Start date
2022-06-29
Completion date
2028-12-31
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Muscle Atrophy, Muscle Tear, Muscle Weakness

Keywords

Gluteus medius, Limp, Abductor, Trendelenburg

Brief summary

Residual limping after total hip arthroplasty is a serious complication that lacks effective treatment. The purpose of this study is to evaluate a surgical treatment for residual limping and compare its results with non-surgical treatment. Our hypothesis is that surgical treatment followed by physiotherapy increases hip function and reduces limping compared with non-surgical treatment with physiotherapy alone.

Detailed description

Residual limping due to gluteus medius insufficiency after total hip arthroplasty is a serious complication that lacks effective treatment. The purpose of this study is to evaluate surgical reconstruction of gluteus medius using Achilles tendon allograft and compare its results and adverse events with non-surgical treatment. Our hypothesis is that surgical reconstruction followed by physiotherapy increases hip function and reduces limping compared with non-surgical treatment with physiotherapy alone.

Interventions

PROCEDURESurgical reconstruction of gluteus medius with Achilles tendon allograft

Achilles tendon allograft i fixed between the gluteus medius muscle and the greater trochanter

Sponsors

Göteborg University
CollaboratorOTHER
Vastra Gotaland Region
CollaboratorOTHER_GOV
The Swedish Society of Medicine
CollaboratorOTHER
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial with the option of crossover in the control group after a certain period of time.

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Persisting limping with positive Trendelenburg's sign for at least 12 months after total hip arthroplasty * Rupture/avulsion of the gluteus medius tendon verified with ultrasound or MRI * Leg length discrepancy of less than 1 cm * Femoral offset discrepancy of less than 25%

Exclusion criteria

* Neuromuscular disorders

Design outcomes

Primary

MeasureTime frameDescription
Oxford Hip Score (OHS)12 monthsPatient-reported hip function measured in a scale 0-48

Secondary

MeasureTime frameDescription
Hip abduction torque12 monthsAbduction torque in the frontal plane measured in Nm/Kg with gait analysis
University of California Level of Activity (UCLA)12 monthsPatient-reported activity level measured with in a rank scale 0-10
Trendelenburg's sign12 monthsPresence or abscence of Trendelenburg's sign as binary outcome (yes/no)
Euroqol visual analog scale (EQVAS)12 monthsPatient-reported health-related quality of life measured with the euroqol visual analog scale 0-100
Adverse events12 monthsAll complications resulting in contact with health care provider within one year.
Euroqol 5 dimension 5 level index (EQ5D-5L)12 monthsPatient-reported health-related quality of life measured with swedish version of the euroqol 5 dimension 5 level index in a scale 0-1

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026